ArticleJDS communications2025
Needle-free injection device for administration of cloprostenol to induce luteolysis in lactating dairy cows.
Article in JDS communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The intersection of biology and advanced technologies defines the future of dairy reproductive management.JDS communications · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this study was to evaluate the effectiveness of using a needle-free injection system for the intramuscular delivery of cloprostenol in lactating dairy cows. Twenty-six lactating Holstein dairy cows were randomly assigned to 1 of 3 treatments: (1) a single needle-free injection of 2 mL (0.5 mg) cloprostenol i.m. (NFI-PG; n = 10); (2) a single conventional needle injection of 2 mL (0.5 mg) cloprostenol i.m. (NDL-PG; n = 10); or (3) a needle-free injection of 2 mL physiological saline i.m. (CNTL, n = 6). Outcome measurements included corpus luteum (CL) size and blood flow via ovarian ultrasound, as well as progesterone (P4) and plasma cortisol (CORT) concentrations, all assessed at predetermined time points. Data were analyzed using a mixed model with the cow as the experimental unit, and fixed effects of group, day, and the group-by-day interaction. No significant differences were observed in P4 and CL outcome measures between the NFI-PG and NDL-PG groups. Both NFI-PG and NDL-PG cows exhibited similar decreases in P4 across all time points. In contrast, no significant changes in P4 concentrations and CL measures were observed in the CNTL group. Thus, the CNTL cows exhibited significantly higher P4 concentrations from 8 to 92 h compared with the NFI-PG and NDL-PG groups. Regression of CL, as indicated by a decrease in CL volume, blood flow, and P4 concentrations, was observed following both NDL-PG and NFI-PG injections, but not in the CNTL group. The NFI-PG cows had significantly lower CORT levels throughout the entire time period compared with both CNTL and NDL-PG cows. In conclusion, the use of a needle-free injection system for cloprostenol delivery resulted in similar outcomes to conventional needle injections, with comparable decreases in P4 and CL measures in lactating dairy cows and lower CORT concentrations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.